Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bunse, Mario Dr. (1) Clauß, Julian (1) Costanza, Mariantonia Dr. (1) Daniel, Peter Prof. Dr. (1) Hinze, Christian Dr. med. Dipl.-Math. (1) Höpken, Uta Elisabeth PD Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Janz, Martin Dr. (5) Kieback, Elisa Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (2) Lusatis, Simone (1) Mathas, Stephan Dr. (5) Na, Il-Kang Dr. (1) Rehm, Armin Dr. (1) Scheidereit, Claus Prof. Dr. (1) Sczakiel, Henrike (1) Willimsky, Gerald Dr. (3) (-) Blankenstein, Thomas Prof. Dr. (5) (-) Uckert, Wolfgang Prof. Dr. (3) (-) Wollert-Wulf, Brigitte (2) Bioinformatics and Omics Data Science (1) (-) Biologie maligner Lymphome (2) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (2) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Genom-Editierung & Krankheitsmodelle (1) Immundysregulationen in der Onkologie (1) Immunregulation und Krebs (1) Integrative Vaskuläre Biologie (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) Mobile DNA (1) Molekularbiologie von Hormonen im Herz-Kreislaufssystem (1) Molekulare Herz- Kreislaufforschung (1) (-) Molekulare Immunologie und Gentherapie (7) Molekulare Physiologie der somatosensorischen Wahrnehmung (1) Pluripotent Stem Cells (1) Proteom Dynamik (8) Proteomics (1) Proteomics and Metabolomics (1) Psychoneuroimmunologie (1) RNA Biologie und Posttranscriptionale Regulation (1) Systembiologie von Gen-regulatorischen Elementen (1) Transgenics (1) Translationale Tumorimmunologie (1) Zelluläre Neurowissenschaften (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2004 (8) 2005 (10) (-) 2006 (3) 2007 (6) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (13) 2014 (3) 2015 (4) 2016 (5) 2017 (6) (-) 2018 (6) 2019 (7) 2021 (4) 2022 (6) 2023 (6) 2024 (2) 9 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Uckert, Wolfgang Prof. Dr.Wollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Immunologie und Gentherapie 20062018 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 01. Januar 2018 / Cancer Immunol Res A transgenic dual-luciferase reporter mouse for longitudinal and functional monitoring of T cells in vivo M. Szyska S. Herda S. Althoff A. Heimann J. Russ D. D'Abundo T.M. Dang I. Durieux B. Dörken T. Blankenstein I.K. Na 30. August 2018 / Blood Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice D. Hoser C. Schön C. Loddenkemper P. Lohneis A.A. Kühl T. Sommermann T. Blankenstein G. Willimsky 01. August 2018 / Mol Ther CAR T cells with enhanced sensitivity to B cell maturation antigen for the targeting of B cell non-Hodgkin's lymphoma and multiple myeloma J. Bluhm E. Kieback S.F. Marino F. Oden J. Westermann M. Chmielewski H. Abken W. Uckert U.E. Höpken A. Rehm 01. Juni 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel 01. Mai 2018 / Hum Gene Ther Efficient non-viral T cell engineering by Sleeping Beauty minicircles diminishing DNA toxicity and miRNAs silencing the endogenous TCR J. Clauss M. Obenaus C. Miskey Z. Ivics Z. Izsvák W. Uckert M. Bunse 01. August 2018 / Clin Cancer Res Targeting Merkel cell carcinoma by engineered T cells specific to T-antigens of Merkel cell polyomavirus I. Gavvovidis M. Leisegang G. Willimsky N.J. Miller P. Nghiem T. Blankenstein
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. Januar 2018 / Cancer Immunol Res A transgenic dual-luciferase reporter mouse for longitudinal and functional monitoring of T cells in vivo M. Szyska S. Herda S. Althoff A. Heimann J. Russ D. D'Abundo T.M. Dang I. Durieux B. Dörken T. Blankenstein I.K. Na
30. August 2018 / Blood Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice D. Hoser C. Schön C. Loddenkemper P. Lohneis A.A. Kühl T. Sommermann T. Blankenstein G. Willimsky
01. August 2018 / Mol Ther CAR T cells with enhanced sensitivity to B cell maturation antigen for the targeting of B cell non-Hodgkin's lymphoma and multiple myeloma J. Bluhm E. Kieback S.F. Marino F. Oden J. Westermann M. Chmielewski H. Abken W. Uckert U.E. Höpken A. Rehm
01. Juni 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel
01. Mai 2018 / Hum Gene Ther Efficient non-viral T cell engineering by Sleeping Beauty minicircles diminishing DNA toxicity and miRNAs silencing the endogenous TCR J. Clauss M. Obenaus C. Miskey Z. Ivics Z. Izsvák W. Uckert M. Bunse
01. August 2018 / Clin Cancer Res Targeting Merkel cell carcinoma by engineered T cells specific to T-antigens of Merkel cell polyomavirus I. Gavvovidis M. Leisegang G. Willimsky N.J. Miller P. Nghiem T. Blankenstein